Search Results

…unless (1) a country’s legal age for employment or age for completing compulsory education is under 18 and (2) the work is non-hazardous. HUMAN RIGHTS COMPLIANCE Vendors shall (and shall…

…Thermo Fisher Code of Conduct: https://www.ppd.com/who-we-are/company-resources/ethics/ https://globalaes.com/vendor-resources/vendor-code-conduct/ SUPPLY CHAIN DUE DILIGENCE, RISK ASSESSMENT AND MANAGEMENT As part of our initiative to identify and mitigate risk we conduct due diligence prior…

Last Updated August 18, 2023 This website is operated by Acurian, Inc., (“Acurian,” “we,” “our”) on behalf of Accelerated Enrollment Solutions (“AES”).  AES is a business unit comprised of the…

…answer any questions you have. Quality staffing. We partner with top local providers to select and train nurses directly on GxP and protocol, minimizing risk of deviations. Additionally, our oversight…

…directly into AES’s Clinical Research Network, you gain access to neurologists and psychiatrists in 11 countries across the globe with extensive neuroscience experience, including five specialized U.S.-based neurology/psychiatry sites. AES…

…within their community (e.g., outreach to community- and faith-based organizations), as well as through our global network of providers and healthcare systems. We then offer flexible scheduling, virtual first office…

…of disease. AES Experience in Dermatology + Supported Studies + Supported Sites Example Dermatology Indications: Alopecia, atopic dermatitis, dermatitis, juvenile psoriasis, plaque psoriasis, postherpetic neuralgia, psoriasis  Indication details# Trials# of…

…today. AES has in-depth gastroenterology experience, including significant expertise in non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), Crohn’s disease, ulcerative colitis and more. Why AES for gastroenterology clinical trials?…

…us, submit the form below and we’ll get back to you shortly. FDA drug trial snapshot 2020: https://www.fda.gov/media/145718/download Tufts Center for the Study of Drug Development, Impact Report, January/February 2021…